Llwytho...
EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy
Cognitive impairment is a common and often devastating comorbidity of pharmacoresistent epilepsy. The cognitive comorbidity can be both chronic, primarily due to the underlying etiology of the epilepsy, and dynamic or evolving because of recurrent seizures or interictal spikes. There is now consider...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Epilepsia |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4682563/ https://ncbi.nlm.nih.gov/pubmed/23646973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12186 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|